Cargando…

CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells

Development of distant metastasis relies on interactions between cancer and stromal cells. CXCL12, also known as stromal-derived factor 1α (SDF-1α), is a major chemokine constitutively secreted in bone marrow, lymph nodes, liver and lung, playing a critical role in the migration and seeding of neopl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ieranò, Caterina, D’Alterio, Crescenzo, Giarra, Simona, Napolitano, Maria, Rea, Giuseppina, Portella, Luigi, Santagata, Assunta, Trotta, Anna Maria, Barbieri, Antonio, Campani, Virginia, Luciano, Antonio, Arra, Claudio, Anniciello, Anna Maria, Botti, Gerardo, Mayol, Laura, De Rosa, Giuseppe, Pacelli, Roberto, Scala, Stefania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646345/ https://www.ncbi.nlm.nih.gov/pubmed/31332163 http://dx.doi.org/10.1038/s41419-019-1796-6

Ejemplares similares

Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
por: D’Alterio, Crescenzo, et al.
Publicado: (2019)

New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
por: D’Alterio, Crescenzo, et al.
Publicado: (2020)

Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
por: Trotta, Anna Maria, et al.
Publicado: (2018)

A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors
por: Santagata, Sara, et al.
Publicado: (2017)

Inhibition of stromal CXCR4 impairs development of lung metastases
por: D’Alterio, Crescenzo, et al.
Publicado: (2012)

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies
por: Ieranò, Caterina, et al.
Publicado: (2022)

Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases
por: Portella, Luigi, et al.
Publicado: (2013)

CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
por: Neve Polimeno, Maria, et al.
Publicado: (2015)

Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients
por: Napolitano, Maria, et al.
Publicado: (2015)

CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients
por: D’Alterio, Crescenzo, et al.
Publicado: (2022)

CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR
por: Circelli, Luisa, et al.
Publicado: (2016)

CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment
por: Santagata, Sara, et al.
Publicado: (2021)

Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types
por: Scognamiglio, Giosuè, et al.
Publicado: (2016)

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells
por: Botti, Gerardo, et al.
Publicado: (2017)

Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients
por: D’Alterio, Crescenzo, et al.
Publicado: (2022)

Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer
por: Santagata, Sara, et al.
Publicado: (2017)

Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer
por: Cioffi, Michele, et al.
Publicado: (2015)

CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells
por: Ieranò, C, et al.
Publicado: (2014)

Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides
por: Tomassi, Stefano, et al.
Publicado: (2022)

New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM
por: Scala, Stefania, et al.
Publicado: (2020)

Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis
por: Aversa, I., et al.
Publicado: (2017)

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol
por: Ottaiano, Alessandro, et al.
Publicado: (2019)

Chitosan-Based Polyelectrolyte Complexes for Doxorubicin and Zoledronic Acid Combined Therapy to Overcome Multidrug Resistance
por: Giarra, Simona, et al.
Publicado: (2018)

Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

The effects of the use of platelet-rich plasma gel on local recurrence in an animal model of human fibrosarcoma
por: Barbieri, Antonio, et al.
Publicado: (2019)

Proposed algorithm during COVID-19 pandemic for patient management in medical retina clinic
por: Corazza, Paolo, et al.
Publicado: (2020)

CXCL12/SDF-1 in IgG4-Related Disease
por: Capecchi, Riccardo, et al.
Publicado: (2021)

A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice
por: Tagliamonte, Maria, et al.
Publicado: (2016)

BRACS: A Dataset for BReAst Carcinoma Subtyping in H&E Histology Images
por: Brancati, Nadia, et al.
Publicado: (2022)

Effect of electrochemotherapy on human herpesvirus 8 kinetics in classic Kaposi sarcoma
por: Starita, Noemy, et al.
Publicado: (2017)

Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival
por: Panza, Elisabetta, et al.
Publicado: (2016)

Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting
por: Petrizzo, Annacarmen, et al.
Publicado: (2017)

Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma
por: Sabbatino, Francesco, et al.
Publicado: (2020)

Cross Talk of Macrophages with Tumor Microenvironment Cells and Modulation of Macrophages in Cancer by Virotherapy
por: Di Somma, Sarah, et al.
Publicado: (2021)

Conformational Ensembles Explored Dynamically from Disordered Peptides Targeting Chemokine Receptor CXCR4
por: Vincenzi, Marian, et al.
Publicado: (2015)

Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
por: Carriero, Maria Vincenza, et al.
Publicado: (2017)

Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study
por: von Arx, Claudia, et al.
Publicado: (2020)

The Ratio of GrzB(+) − FoxP3(+) over CD3(+) T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma
por: Scognamiglio, Giosuè, et al.
Publicado: (2021)

Influence of radiopaque fillers on physicochemical properties of a model epoxy resin-based root canal sealer
por: COLLARES, Fabrício Mezzomo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_grllkudkr46fqtt1rhq1om7rs8